Explore Stanford technologies available for licensing:

Stanford inventors have found that Stanniocalcin 2 (STC2) treatment following stoke leads to improved functional recovery and a pharmaceutical composition containing STC2 as an active ingredient can be used to facilitate post stroke recovery.

In 2021, almost 200,000 patients were diagnosed with leukemia and other blood and immune diseases in the US.

Researchers in the Lee lab have discovered a totally novel approach to restore the impairment of empathy associated with many neurological disorders and mental illnesses.

Stanford researchers in the Woo Lab have developed a novel device that allows for direct visual assessment of the aortic valve apparatus under physiologic pressure in aortic valve procedures.

Stanford researchers in the Multi-Robot Systems Lab have developed a software model for predicting risk-aware human behavior in multi-agent traffic scenarios that include a range of human driver behavior from aggressive (speeding, overtaking, sudden zigzagging, and lane-change

Stanford inventors in the Katrin Svensson laboratory have identified the protein Isthmin-1 (ISM1) as a treatment for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

Researchers at Stanford have identified a novel method of use for the drug T-5224 in the prevention of abdominal adhesion.

Researchers at Stanford have reported the first high energy density shape memory polymer based on the formation of strain-induced supramolecular nanostructures, which immobilize stretched chains to store entropic energy.

Researchers at Stanford University have engineered chemically crosslinked in situ-forming gels that can mimic corneal stroma.

Stanford inventors have developed the CasKAS method for profiling CRISPR off-targets using single-stranded DNA (ssDNA) mapping. Binding of CRISPR protein to DNA generates ssDNA structures, which can be a sensitive biochemical signal of CRISPR occupancy.

Stanford researchers in the Swartz lab have developed a method for improving the productivity of biosynthetic processes via enzymatic detoxification of aberrant forms of NAD(P)H.

Stanford inventors have developed a cell-free method for carbon-negative biosynthetic production of commodity biochemicals by using hydrogen gas as a source of reducing equivalents.

Stanford researchers in the Swartz lab have proposed a method to synthesize metabolic cofactors from inexpensive substrates for protein synthesis and commodity production applications.

Dr. Maheen Mausoof Adamson and colleagues have developed a personalized non-verbal communication device and associated app for post-stroke expressive aphasia patients.

Researchers at Stanford have developed a generalized protease-responsive platform, called RELEASE, to control the secretion and display of proteins.